Home > Press release

 

 

ARCHIVE PRESS RELEASE
Chiesi Global Rare Diseases Announces FDA Approval of Lamzede® (velmanase alfa-tycv) for Alpha-Mannosidosis
Chiesi appoints Giuseppe Accogli as new Group CEO
Important recognitions for Chiesi Group from the Carbon Disclosure Project (CDP) and Cerved Rating Agency
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
Chiesi Group communicates that it is not involved in the events concerning the Holostem company
Chiesi Group endorses the Manifesto Against Gender-Based Violence
Chiesi Group’s new Biotech Center of Excellence brings the future of medicine to Parma
Chiesi Group and Aptar partner to bring to market Disease Management Platform for Patients with Asthma and COPD
Chiesi is recertified as a B Corp and sets new tougher objectives for action by 2025
Chiesi Group brings together experts to discuss care for respiratory patients and presents a new treatment option for COPD at ERS Congress